Earnings Per Share

6 Months Ended

Mar. 31, 2024

As discussed in Note 9 - Equity, the Company has Class A common stock and Class B common stock. Because the only differences between the two classes of common stock are related to voting rights, conversion rights and transfer restrictions applicable to shares of Class B common stock, the Company has not presented earnings per share under the two-class method, as the earnings per share are the same for both Class A common stock and Class B common stock. The following table summarizes the weighted-average number of basic common shares outstanding and the calculation of basic earnings per share for the periods presented (unaudited in thousands, except share and per share amounts):


	For the Three Months Ended March 31,				For the Six Months Ended March 31,
	2024		2023		2024		2023
Numerator
Net income (loss) attributable to common stockholders	$	(1,124)	$	(5,481)	$	8,719	$	(3,589)
Denominator
Weighted average number of common shares outstanding, basic	51,938,216		51,827,365		51,915,069		51,826,143
Net income (loss) per common share attributable to common stockholders, basic	$	(0.02)	$	(0.11)	$	0.17	$	(0.07)

The following table summarizes the calculation of the weighted-average number of diluted common shares outstanding and the calculation of diluted earnings per share for the periods presented (unaudited in thousands, except share and per share amounts):


	For the Three Months Ended March 31,				For the Six Months Ended March 31,
	2024		2023		2024		2023
Numerator
Net income (loss) attributable to common stockholders	$	(1,124)	$	(5,481)	$	8,719	$	(3,589)
Denominator
Weighted average number of basic common shares outstanding, basic	51,938,216		51,827,365		51,915,069		51,826,143
Effect of dilutive securities:

Restricted stock grants	—		—		608,031		—
Weighted average number of diluted common shares outstanding:	51,938,216		51,827,365		52,523,100		51,826,143
Net income (loss) per diluted common share attributable to common stockholders	$	(0.02)	$	(0.11)	$	0.17	$	(0.07)